Mineralocorticoid receptor antagonist in heart failure: Past, present and future perspectives.

Int J Cardiol Heart Vessel · 2014 · PMC5801434 · PMID 29450163

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

A subgroup analysis from the RALES trial revealed a highly significant decrease in the serum levels of PIIINP among patients treated with spironolactone [34] .

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.